ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
抗疫概念
878.789
-11.619
-1.30%
手動刷新
漲家數:
3
跌家數:
14
平家數:
- -
市盈率:
- -
高:
889.460
開:
889.460
低:
870.070
收:
890.408
成交量:
3.01億
成交額:
22.54億
市值:
5,928.82億
流通市值:
4,916.77億
資料載入中...
總覽
新聞
港股異動 | 石藥集團(01093)升逾4% SYS6010近日再獲國家藥監局納入突破性治療品種名單
智通财经
·
09/03
創新藥企密集進入臨床數據驗證期,石藥集團升逾4%!華寶基金港股通創新藥ETF(520880)再收半年線!
新浪基金
·
09/03
中國生物製藥早盤升逾4% TQB6426獲FDA批准開展臨床
新浪港股
·
09/03
港股異動 | 中國生物製藥(01177.HK)早盤漲近5% TQB6426獲FDA批准開展臨床 擬用於晚期惡性腫瘤治療
智通财经
·
09/03
港股開盤向好 恒指高開0.68% 信達生物(01801)漲3.73%
金吾财讯
·
09/03
國家醫保局:不要將病種支付標準與醫務人員績效工資掛鈎;2連板小方製藥披露股價異動公告丨醫藥早參
每日经济新闻
·
09/02
mRNA腫瘤療法重大突破!京東健康(06618.HK)與立康生命科技簽署戰略合作協議
智通财经
·
09/02
康希諾生物上半年海外收入按年增長4724.19% 體系化「出海」打開增長空間
证券日报网
·
09/02
勁方醫藥-B(02595)9月2日斥資107.63萬港元回購3.9萬股
智通财经
·
09/02
貝萊德在復星醫藥的H股好倉比例上升0.22%至7.19%
南方财经网
·
09/02
大行評級丨傑富瑞:下調比亞迪電子目標價至25港元,維持「持有」評級
格隆汇
·
09/02
恒指、恒科飄綠,房地產、銀行走強,汽車股下挫;美團、小米、零跑上漲,蔚來、快手、理想下跌 | 港股收盤
每日经济新闻
·
09/02
港股收盤(09.02) | 恒指收跌0.07% 部分醫藥股逆市走高 汽車、有色金屬等承壓
智通财经
·
09/02
迪哲醫藥二度遞表港交所:上半年虧損超2億,「小眾靶點」天花板與現金流雙重壓力並存
蓝鲸财经
·
09/02
前8月全球醫藥投融資按年增72%,行情回暖可期?
新浪基金
·
09/02
禮邦醫藥-B(09637)股價下跌8.404%,現價港幣$27.9
阿斯达克财经
·
09/02
石藥集團(01093)出現大手買入79萬股,成交價$9.2,涉資726.8萬
阿斯达克财经
·
09/02
《股市簡訊》中國泰格醫藥A/H股齊跌,投行富瑞下調目標價
路透中文
·
09/02
歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
新浪港股
·
09/02
港股異動 | 歌禮制藥-B(01672.HK)升逾5% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
智通财经
·
09/02
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1515/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":878.7892,"timestamp":1789114133774,"preClose":890.4082,"halted":0,"volume":300625831,"delay":0,"changeRate":-0.013049,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-11.619019,"latestTime":"09-11 16:00:00","open":889.45984,"high":889.45984,"low":870.06995,"amount":2253603899,"amplitude":0.021776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.318473,"peRate":17.086203,"turnoverRate":0.003644,"increases":3,"decrements":14,"flats":0,"marketCap":592881820352,"floatMarketCap":491676687872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.45984,"amplitude":0.021776,"preClose":890.4082,"low":870.06995,"pbRate":"1.318473","latestPrice":878.7892,"volume":300625831,"delay":0,"open":889.45984,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":936.431,"twentyDayClose":912.416,"sixtyDayClose":852.523,"secType":"PLATE","market":"HK","turnoverRate":0.003644,"peRate":17.086203,"marketCap":592881820352,"floatMarketCap":491676687872,"timestamp":1789114133774,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664823065","title":"港股異動 | 石藥集團(01093)升逾4% SYS6010近日再獲國家藥監局納入突破性治療品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823065","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664823065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:14","pubTimestamp":1788405245,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,石药集团涨超4%,截至发稿,涨4.09%,报9.545港元,成交额7.59亿港元。消息面上,石药集团发布公告,本集团开发的SYS6010(该产品)近日再获中国国家药品监督管理局纳入突破性治疗品种名单,拟定适应症为既往接受过免疫及含铂化疗治疗失败的复发或转移性头颈鳞癌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","LU1807302812.USD","LU1008478684.HKD","BK1515","LU1328277881.USD","LU0140636845.USD","LU1813983027.USD","BK1191","LU1226288253.USD","HK0000165453.HKD","LU1152091168.USD","LU1993786604.SGD","BK1521","SG9999004220.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1951186391.HKD","LU1960683339.HKD","BK4585","LU1226287529.USD","LU1226288170.HKD","01093","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU0314109678.HKD","IE0008368742.USD","LU0501845795.SGD","LU0315179316.USD","LU0072913022.USD","BK4588","IE00B543WZ88.USD","LU0880133367.SGD","LU2039709279.SGD","LU1226287792.SGD","LU0067412154.USD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","IE0008369823.USD","LU0326950275.SGD","KURE","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664231028","title":"創新藥企密集進入臨床數據驗證期,石藥集團升逾4%!華寶基金港股通創新藥ETF(520880)再收半年線!","url":"https://stock-news.laohu8.com/highlight/detail?id=2664231028","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664231028?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 10:52","pubTimestamp":1788403920,"startTime":"0","endTime":"0","summary":"9月3日,港股创新药链继续活跃,创新药龙头公司领涨,石药集团、中国生物制药双双涨超4%。纯正创新药指数——恒生港股通创新药精选指数一度冲高逾2%,跟踪该指数的港股通创新药ETF华宝盘中再收半年线。中金公司提示,创新药较多公司进入临床数据验证阶段,值得自下而上关注。据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中,31家上半年实现盈利,归母净利同比正增长的有33家,占比近7成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpkry1034045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0501845795.SGD","IE00B5MMRT66.SGD","LU2039709279.SGD","BK1191","IE00BZ08YS42.EUR","BK1161","LNGR","LU1152091168.USD","520880","LU0067412154.USD","LU1226287792.SGD","LU0072913022.USD","LU1226287875.USD","159316","IE00B031HY20.USD","LU1807302812.USD","01093","BK1521","KURE","LU1152091754.HKD","FLHK","LU1813983027.USD","SG9999004220.SGD","LU1951186391.HKD","BK1574","MEDX","LU0880133367.SGD","LU0315179316.USD","IE00B543WZ88.USD","LU0326950275.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1226288170.HKD","06978","LU0314109678.HKD","LU1960683339.HKD","LU1993786604.SGD","LU1226287529.USD","IBBQ","BK1515","IE00BZ08YT58.USD","LU0140636845.USD","159992","LU1226288253.USD","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238088","title":"中國生物製藥早盤升逾4% TQB6426獲FDA批准開展臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238088","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238088?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 10:28","pubTimestamp":1788402480,"startTime":"0","endTime":"0","summary":"模拟交易客户端中国生物制药早盘涨近5%。截至发稿,股价上涨4.47%,现报5.50港元,成交额1.54亿港元。中国生物制药旗下正大天晴自主研发的创新型GPC3抗体药物偶联物TQB6426,于近日获得美国食品药品监督管理局临床试验默认许可,拟用于晚期恶性肿瘤治疗。至此,TQB6426拿下中美两大核心医药市场临床准入资质,成为公司创新药全球化开发的重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-03/doc-iniqpeka1141170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01177","BK1589","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YR35.GBP","LABU","BK1521","BK4588","BK4585","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664459828","title":"港股異動 | 中國生物製藥(01177.HK)早盤漲近5% TQB6426獲FDA批准開展臨床 擬用於晚期惡性腫瘤治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2664459828","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664459828?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 09:59","pubTimestamp":1788400759,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","BK1589","IE00BZ08YT58.USD","HK0000165453.HKD","BK1515","BK1191","BK1521","01177","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664840055","title":"港股開盤向好 恒指高開0.68% 信達生物(01801)漲3.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664840055","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664840055?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 09:26","pubTimestamp":1788398766,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘向好,恒指高开0.68%,国企指数高开0.75%,恒生科技指数高开0.71%。信达生物涨3.73%,联想集团涨3.33%,老铺黄金涨2.60%,京东健康涨2.43%,农夫山泉涨2.39%,网易涨1.82%。京东健康高开2.43%,公司与立康生命科技签署战略合作协议。外围气氛持续紧张,投资者忧虑债息高企及地缘政局紧张,不过考虑到早前跌势较大,短线大市有机会展现技术反弹,预料指数继续于25,000至26,000点水平上落。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGVhNjVkZTQ2ODU4ZWQyYjc4YjcyMmRkNWUzMjAzNTczNzI1NTIy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990504","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","BK1247","LU0327786744.USD","02800","LU0828237510.HKD","07200","LU1211504680.USD","LU0128525689.USD","LU0244354667.USD","LU0605514214.HKD","IE0009570106.USD","LU1719994722.HKD","LU0502904849.HKD","LU2097828631.EUR","SG9999003461.SGD","SG9999006514.SGD","BK1575","80291","LU0329678170.USD","BK1193","LU0320764755.SGD","LU2097828714.EUR","LU1226287792.SGD","LU0441854154.USD","LU1634259557.SGD","HSI","DRGN","09926","81024","600690","LU0594300179.USD","LU1769817179.HKD","IE00BZ08YR35.GBP","LU2048586759.USD","LU0348805143.USD","MCHmain","HK0000165453.HKD","LU0211977185.USD","LU1046422090.SGD","LU0329678337.USD","BK1607","07500","BK1200","LU1675838814.USD","LU1226288097.SGD","LU2097828474.EUR","LU0149721374.USD","LU1366334651.USD","BK1609","LU0784639295.USD","LU2328871848.SGD","LU0049853897.USD","LU1634259391.SGD","LU0877626530.USD","LU0650527681.SGD","LU0708995583.HKD","LU0181495838.USD","BK1610","HK0000320223.HKD","LU0231483743.USD","IE0008368742.USD","09633","LU1969619763.USD","LU0675040207.SGD","SOCL","LU0348735423.USD","LU1688375341.USD","BK1180","LU0293314216.USD","LU0791591158.USD","LU1655091459.SGD","LU0310800965.SGD","IE00B067MR52.USD","BK1589","LU0320764599.SGD","BK1608","BK1161","LU1794554557.SGD","LU1831875114.USD","LU1328615791.USD","LU1481107354.HKD","LU0463099449.HKD","BK1571","IE00BMCWC346.EUR","BK1570","IE00BZ08YT58.USD","LU0633140560.USD","LU0898667661.SGD","LU0531971595.HKD","LU0348783662.USD","LU0633140727.USD","03115","LU1251922891.USD","LU0149534421.HKD","LU0326950275.SGD","IE00BQJZWZ67.USD","BK1590","HK0000320264.USD","LU2488822045.USD","LU0683595622.HKD","LU1224444064.USD","LU1808992512.USD","02382","LU0455707207.USD","LU0359201612.USD","SG9999001093.SGD","86618","LU1048588211.SGD","BK1214","LU0359201885.HKD","LU2476274720.SGD","09115","LU0540923850.HKD","LU0264606111.USD","06618","02833","LU0871576103.HKD","IE0003795394.USD","LU0328353924.USD","LU0405327494.USD","IE00B5MMRT66.SGD","LU2097828805.USD","LU0348825331.USD","LU1785774172.SGD","01024","HHImain","IE00B97KM107.HKD","LU1770034418.SGD","LU0890818403.SGD","LU1303224171.USD","LU1807302812.USD","LU0588545730.USD","LU1951186391.HKD","LU0469268626.HKD","00992","NTES","SG9999006597.SGD","83115","IE0032431581.USD","IE00BWDBJ730.SGD","LU1328277881.USD","LU0048580855.USD","FDNI","LU0456827905.SGD","LU1497733631.SGD","LU1880383440.USD","KURE","BK1588","LU2097828557.USD","LU0164880469.USD","LU0594300419.USD","IE00BYV24P56.USD","LU1119993845.HKD","LU1497734951.SGD","BK1095","80992","LU0348827113.USD","82800","BK1510","LU0106252389.USD","LU0106959298.USD","LU0737861699.HKD","NNFSF","IE0032834883.USD","LU2279701549.SGD","LU0543330483.HKD","LU1282651121.HKD","03037","LU1226288253.USD","BK1521","LU0572939691.SGD","TCHI","LU1267930227.SGD","LU0821914370.USD","LU0052756011.USD","LU0561508036.HKD","LU0210526637.USD","LU0501845795.SGD","IE00BPRC5H50.USD","LU0051755006.USD","LU0572944931.SGD","BK1578","BK1104","LU0117841782.USD","LU1880383366.USD","BK1227","LU0431992006.USD","LNVGY","LU0572940350.SGD","HSTECH","LU0072913022.USD","LU1366334578.USD","06181","LU0314109678.HKD","IE00B543WZ88.USD","LU0348784397.USD","LU0188438112.USD","LU1981816686.USD","LU0588546209.SGD","BK1557","LU0672654166.SGD","IE00B0JY6N72.USD","LU0169518387.USD","06690","BK1591","LU0140636845.USD","KWEB","00857","LU1720050803.USD","BK1526","IE0031814852.USD","LU1115378108.SGD","LU0348767384.USD","IE00B29SXG58.USD","LU1813983027.USD","LU0823413660.USD","IE0034224299.USD","LU1235295612.USD","SGXZ86797644.SGD","KSTmain","LU0128522157.USD","LU0737861772.HKD","BK1531","BK1574","LU1226287875.USD","IE0003851619.USD","BK1583","LU1188198961.HKD","BK1170","LU0405327148.USD","00291","LU0823413587.USD","LU0164865239.USD","SG9999001846.SGD","LU0052750758.USD","BK1528","LU0588545904.SGD","LU0831103253.SGD","HK0000306701.USD","IE0008369823.USD","IE00B031J352.USD","IE0003895053.USD","LU0868486357.SGD","LU2242644610.SGD","LU0359202008.SGD","LU0315178854.USD","HK0000306685.HKD","LU1655091616.SGD","LU0039217434.USD","IE00B031HY20.USD","LU2293587155.HKD","LU1224709979.USD","SG9999004220.SGD","513600","09999","LU0417516902.SGD","LU0287142896.SGD","IE00B0169L03.USD","BK1615","601857","LU0862451837.USD","CRHKY","LU0072462343.USD","LU0192582467.USD","LU1522347837.USD","LU0640798160.USD","LU0607220059.USD","BK1226","03419","LU0348766576.USD","LU0588545490.SGD","BK1504","LU0049112450.USD","LU1497733557.USD","01801","LU0228659784.USD","LU0456846285.SGD","LU2152927971.USD","BK1544","07300","LU0348783233.USD","LU1282651048.USD","LU0029875118.USD","BNGE","LU2051468812.USD","LU2039709279.SGD","LU1769817096.USD","BK1604","LU0210527791.USD","LU0205439572.USD","LU1048596156.SGD","LU0370786039.SGD","LU0417516738.SGD","LU0117844026.USD","LU0417516571.SGD","IE00BZ08YS42.EUR","LU0593848301.USD","BK1142","LU2399975544.HKD","LU0972618739.USD","LU0173614495.USD","BK1515","SGXZ62798434.SGD","SGXZ90724238.SGD","IE00B19Z5X02.USD","LU1226287529.USD","LU0611395673.USD","LU1226288170.HKD","LU0634319403.HKD","LU0865486749.SGD","LU2257852520.SGD","SG9999014674.SGD","LU2476274308.USD","LU1734074674.USD","LU1023057109.AUD","LU0862451753.SGD","SG9999001051.SGD","LU2778985437.USD","02565","LU0791590937.USD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664120338","title":"國家醫保局:不要將病種支付標準與醫務人員績效工資掛鈎;2連板小方製藥披露股價異動公告丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2664120338","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664120338?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 21:52","pubTimestamp":1788357123,"startTime":"0","endTime":"0","summary":"丨2026年9月3日星期四丨NO.1国家医保局:不要将病种支付标准与医务人员绩效工资挂钩9月2日上午,国家医保局召开新闻发布会,发布按病种付费3.0版分组方案和技术规范。国家医保局有关负责人强调,病种支付标准是医保部门根据客观发生的历史费用、基于患者群体数据形成的费用“均值”,支付方式改革不是医保的“控费”手段和目的,也不可能要求每一个病例都不超过支付标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023863049079.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023863049079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","603207","BK1574","BK0239","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664283814","title":"mRNA腫瘤療法重大突破!京東健康(06618.HK)與立康生命科技簽署戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664283814","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664283814?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 21:03","pubTimestamp":1788354210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SGXZ86797644.SGD","06618","LU0051755006.USD","SGXZ62798434.SGD","BK1591","BK1583","BK1615","BK1571","BK1142","BK1247","BK1589","86618","LU0456827905.SGD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814735","title":"康希諾生物上半年海外收入按年增長4724.19% 體系化「出海」打開增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814735","media":"证券日报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814735?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:31","pubTimestamp":1788352260,"startTime":"0","endTime":"0","summary":"上半年公司实现营业收入5.5亿元,同比增长43.81%;归母净亏损同比大幅收窄。最亮眼的变化来自国际化业务:海外收入1.52亿元,同比增长4724.19%。第二条路,也是本次收入爆发的核心推手:技术与产业化能力“出海”。康希诺生物跑出一套复合模式:成品疫苗销售、疫苗中间品供应、工艺技术转移、海外联合临床开发四线并行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-02/doc-iniqmwqs1387320.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-02/doc-iniqmwqs1387320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1191","BK1515","06185","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815269","title":"勁方醫藥-B(02595)9月2日斥資107.63萬港元回購3.9萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815269","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:06","pubTimestamp":1788347190,"startTime":"0","endTime":"0","summary":"智通财经APP讯,劲方医药-B(02595)发布公告,于2026年9月2日,该公司斥资107.63万港元回购3.9万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159938","BK1161","02595","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818325","title":"貝萊德在復星醫藥的H股好倉比例上升0.22%至7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818325","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:24","pubTimestamp":1788341040,"startTime":"0","endTime":"0","summary":"南财智讯9月2日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在复星医药的H股好仓(L)比例于8月28日从6.97%上升至7.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023862836877.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023862836877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","BK0188","BK0187","BK0175","BK0239","600196","BK0183","BK0196","BK1515","BK0060","BK1593","BK1191","BK0028","02196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890521","title":"大行評級丨傑富瑞:下調比亞迪電子目標價至25港元,維持「持有」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890521","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664890521?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:21","pubTimestamp":1788340894,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1149","BK1515","BK1607","BK1580","BK1504","LU0274383008.USD","BK1589","BK1582","BK1167","LU0348766576.USD","00285","BK1540","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897130","title":"恒指、恒科飄綠,房地產、銀行走強,汽車股下挫;美團、小米、零跑上漲,蔚來、快手、理想下跌 | 港股收盤","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897130","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897130?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:44","pubTimestamp":1788338671,"startTime":"0","endTime":"0","summary":"9月2日,香港恒生指数收跌0.07%,恒生科技指数跌0.74%。消费电子、医疗服务、房地产、银行等板块走强,电源设备、媒体、汽车、软件开发等板块下挫。恒生科技成分股中,美团涨超2.7%,小米集团、MINIMAX、零跑汽车涨超1%,地平线机器人跌超6%,智谱跌超5%,比亚迪股份、比亚迪电子、蔚来跌超3%,快手、理想汽车跌超2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023862797090.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023862797090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0672654166.SGD","SG9999014674.SGD","LU0516422440.USD","LU0456827905.SGD","LU0047713382.USD","LU1813983027.USD","BK1588","LU2506951792.HKD","LU1861219969.SGD","LU0143863784.USD","LU2360107325.USD","LU0577902371.SGD","LU0054450605.USD","02833","03423","LU0823038988.USD","BK1539","LU2476274720.SGD","LU0210526637.USD","LU0289961442.SGD","LU0828237940.HKD","LU1981816686.USD","BK1502","LU1152091754.HKD","LU2125910500.SGD","LU0327786744.USD","LU0359201885.HKD","BK1608","LU0320764243.SGD","LU0531970944.HKD","LU0244354667.USD","LU0501845795.SGD","LU0431992006.USD","IE00BF5LJ272.USD","LU0128522744.USD","LU0577902454.USD","LU0828237510.HKD","HSI","LU1734074674.USD","LU0516423091.SGD","LU0880133367.SGD","BK1615","HSTECH","LU2242644610.SGD","07552","LU1048596156.SGD","LU0164872284.USD","LU0823413660.USD","LU0345776255.USD","HHImain","BK1095","MHImain","LU1048588211.SGD","LU0348825331.USD","IE00BZ08YR35.GBP","LU0348805143.USD","SMOG","BK1521","BK1193","LU1770036033.HKD","LU0261947096.USD","BK1233","LU0577902298.EUR","LU1880383440.USD","LU1303224171.USD","09067","BYDDY","SG9999015945.SGD","IE00BZ08YS42.EUR","LU1188198961.HKD","LU0348827113.USD","LU0449509016.USD","LU1956131251.USD","LU0588545904.SGD","00285","LU0463099449.HKD","LU1102505762.USD","IE0034224299.USD","LU0541502299.USD","LU0128522157.USD","SOCL","SG9999015978.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0269904917.USD","LU0326950275.SGD","LU0540923850.HKD","LU0979878070.USD","LU2045819591.USD","09866","LU0823414551.USD","LU0348767384.USD","LU0531971595.HKD","BK1515","BK1591","LU0456846285.SGD","IE0008369823.USD","LU2148510915.USD","IE00B031HY20.USD","LU0307460666.USD","LU0873338254.USD","LU0054237671.USD","SG9999006597.SGD","LU0417516738.SGD","SG9999001903.USD","LU0516422366.SGD","LU1688375341.USD","LU0650527681.SGD","LU0084288322.USD","LU0106252389.USD","02015","LU0051755006.USD","LU0049853897.USD","03419","LU0511384066.AUD","LU0345775950.USD","LU1323998911.USD","03067","LU1794554557.SGD","LU0737861699.HKD","LU0320764599.SGD","LU0287142896.SGD","LU0823426480.USD","LU1770034418.SGD","LU2097828805.USD","LU0577902538.SGD","LU0675040207.SGD","LU0823397103.USD","LU0211977185.USD","03033","LU0588546209.SGD","LU0505663152.USD","IDRV","SG9999006514.SGD","81211","IE00BPRC5H50.USD","LU0588545730.USD","LU0708995153.HKD","METmain","SG9999002828.SGD","LU0149721374.USD","LU0561508036.HKD","02800","82800","LU0164880469.USD","LU1102505929.USD","HMTD.SI","BK1575","LU1242518857.USD","LU2778985437.USD","LU0823413587.USD","LU0326948709.USD","LU0052750758.USD","LU0348788117.USD","NIO.SI","LU0348766576.USD","LU2152927971.USD","LU0289739343.SGD","LU0165289439.USD","LU0469268626.HKD","LU0823040885.USD","IE00BD6J9T35.USD","LU0856984785.SGD","LU0169518387.USD","BK1590","BK1582","LI","MPNGY","LU0868486357.SGD","LU1961090484.USD","03088","LU1993786604.SGD","LU1328277881.USD","LU0175139822.USD","LU0417516902.SGD","09863","81810","LU0594300179.USD","LU0067412154.USD","BK1506","LU0229945570.USD","IE00B29SXG58.USD","LU0509642566.USD","09088","LU0196878994.USD","BK1583","LU1008478684.HKD","LU0254981946.USD","LU1719994722.HKD","LU0918141705.HKD","LU0214875030.USD","LU0132412106.USD","07500","01810","SG9999002562.SGD","LU0315178854.USD","LU0117841782.USD","LU2087589342.USD","LU2294711473.HKD","LU0918141887.USD","LU1064130708.USD","BK1540","LU0819123356.HKD","NIO","LU0823426308.USD","LU0348814723.USD","LU0181495838.USD","BK1594","LU0259732245.USD","LU0449515922.USD","BK1604","SG9999015952.SGD","LU0516423174.USD","KSTmain","09115","03690","LU0261950983.USD","LU0878005551.USD","03032","LU1960683339.HKD","BK1523","SG9999002463.SGD","LU0589944569.HKD","LU0633140560.USD","LU1282648689.USD","LU0441854154.USD","HK0000286598.CNH","LU0348816934.USD","LU2257852520.SGD","FDRV","LU1675838814.USD","LU1328615791.USD","LU1105468828.SGD","BK1522","07226","03417","LU0611395673.USD","513600","LU1481107354.HKD","BK1142","LU0289960550.SGD","LU0516422952.EUR","LU1152091168.USD","LU0543330566.HKD","LU0823397285.USD","LU0455707207.USD","01024","LU0359201612.USD","LU0231483743.USD","LU1720050803.USD","LU0348735423.USD","LU2039709279.SGD","LU0499858438.USD","HYDD.SI","LU1868837722.USD","LU2249611893.SGD","LU0572944931.SGD","LU1808992512.USD","SG9999001226.SGD","01211","HXXD.SI","LU0228659784.USD","LU0359202008.SGD","LU1861214812.USD","LU1880383366.USD","LU0072462343.USD","LU2294711713.HKD","LU2449936058.SGD","LU0011963245.USD","07200","LU0594300419.USD","LU2348774022.SGD","LU2226246903.HKD","BK1607","IE0032431581.USD","LU0072913022.USD","DRGN","LU1868838027.USD","BK1589","LU0683595622.HKD","LU0865486749.SGD","BK1167","BK1580","81024","LU0320764755.SGD","LU0143863198.USD","LU0819121731.USD","LU1242518931.SGD","LU1023057109.AUD","LU0823039010.USD","LU0605514214.HKD","BK1610","LU0577902611.USD","LU0708995583.HKD","LU2097828714.EUR","LU1064131003.USD","SG9999001093.SGD","LU0164865239.USD","07300","LU1831875114.USD","83115","LU0048580855.USD","IE00B0JY6N72.USD","LU2097828474.EUR","LU1807302812.USD","IE00B5MMRT66.SGD","LU0797268264.HKD","BK1587","LU0700851271.USD","LU1868837565.USD","HK0000165453.HKD","LU2097828557.USD","MCHmain","03115","BK1504","LU0140636845.USD","BK1119","LU0370786039.SGD","LU2399975544.HKD","LU2097828631.EUR","BK1509","LU0821914370.USD","LU0048597586.USD","LU0823414478.USD","XIACY","03037","LU2476274308.USD","LU0871576103.HKD","LU0499858602.USD","LU1226287529.USD","LU0593848301.USD","LU0029875118.USD","BK1618","LU0274383008.USD","LU0314109678.HKD","MIUmain","IE00BZ08YT58.USD","LU0029874905.USD","SG9999000327.SGD","SG9999015986.USD","SG9999003461.SGD","BK1149","LU0173614495.USD","LU0502904849.HKD","LU2357125470.USD","SG9999001689.USD","IE00B3M56506.USD","LU0588545490.SGD","LU0543330483.HKD","LU0634319403.HKD","SG9999000459.SGD","KWEB","LU1251922891.USD","002594","LU0039217434.USD","LU0828238088.HKD","LU0251144936.SGD","LU0823041008.USD","02837","LU1224709979.USD","LU0043850808.USD","LU0633140727.USD","LU2153592121.USD","LU0235996351.USD","LU0541501648.USD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892707","title":"港股收盤(09.02) | 恒指收跌0.07% 部分醫藥股逆市走高 汽車、有色金屬等承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892707","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892707?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:26","pubTimestamp":1788337611,"startTime":"0","endTime":"0","summary":"截至收盘,恒生指数跌0.07%或18.52点,报25311.21点,全日成交额2166.91亿港元;恒生国企指数跌0.15%,报8450.1点;恒生科技指数跌0.74%,报4517.16点。汽车股普遍承压。有色金属走势低迷。部分医药股表现亮眼。新意网集团发布截至2026年6月30日止的全年业绩,该集团取得收入31.17亿港元,同比增加6.09%;公司股东应占溢利11.46亿港元,同比增加16.96%;每股基本盈利28.07港仙。建滔积层板上月底宣布2026年以来第七次宣布涨价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07200","RJZ","513600","BK1190","01417","BK1583","82800","01208","00568","BK1588","159871","BK1542","VXUS","BK1594","BK1574","83115","BK4588","IDRV","BK1515","03115","000819.SH","HSImain","159938","MHImain","BK1539","BK1161","HSI","09115","LU1794554557.SGD","BK1592","03419","165316","07300","02015","07500","02800","BK1587","BK1158","03037","BK4585","09939","KCAI","01686","MCHmain","BK1202","02833","BK1575","02096","HHImain","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894762","title":"迪哲醫藥二度遞表港交所:上半年虧損超2億,「小眾靶點」天花板與現金流雙重壓力並存","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894762","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894762?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:46","pubTimestamp":1788335190,"startTime":"0","endTime":"0","summary":"目前,迪哲医药两款核心产品舒沃哲和高瑞哲均已进入国家医保目录。截至2026年中,迪哲医药无控股股东和实际控制人。就在9月1日,迪哲医药发布公告称,公司与阿斯利康签署《许可协议》,授予阿斯利康在全球范围内独家开发、商业化舒沃哲的权利。不过,市场依然对两款产品的天花板存在争议。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788335043232116627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IPOS","BK1515","159938","159399","BK1161","BK1574","SPHQ","BK4588","BK4585","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894186","title":"前8月全球醫藥投融資按年增72%,行情回暖可期?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894186","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894186?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:39","pubTimestamp":1788334740,"startTime":"0","endTime":"0","summary":"据机构最新数据显示,2026年前8个月全球医药投融资明显回暖,全球药品一、二级融资金额合计538亿美元、同比增长72%,约为2025年全年的92%。截至8月30日,5500余家A股上市公司披露上半年研发投入情况,合计研发投入超过8100亿元,同比增长超过7%,生物医药成为上半年A股公司投入研发资金的“高地”之一。其中,以H股42家和A股58家创新药企业为样本,2026年上半年收入、归母净利润增速分别达21.3%、88.8%,显著优于医药板块整体水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-09-02/doc-iniqmmyy2904992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1161","BK1574","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664895554","title":"禮邦醫藥-B(09637)股價下跌8.404%,現價港幣$27.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2664895554","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664895554?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 11:55","pubTimestamp":1788321300,"startTime":"0","endTime":"0","summary":"[下跌股]礼邦医药-B(09637) 股价在上午11:55比前收市价下跌8.404%,现股价为港币$27.9。至目前为止,今日最高价为$30.5,而最低价为$27.9。总成交量为43.97万股,总成交金额为港币$1.28千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609023368/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609023368/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","09637","BK1574","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489532","title":"石藥集團(01093)出現大手買入79萬股,成交價$9.2,涉資726.8萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489532","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489532?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 11:55","pubTimestamp":1788321300,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在上午11:55出现大手买入,成交量为79万,成交价为港币$9.2,涉资726.8万。至目前为止,股价跌0.325%,今日最高价为$9.375,而最低价为$9.13,总成交量为3.134千万股,总成交金额港币$2.897亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609024497/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609024497/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00B031HY20.USD","LU0326950275.SGD","BK1521","LU1226288170.HKD","LU1993786604.SGD","LU0315179316.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1152091754.HKD","SG9999004220.SGD","KURE","IE0008368742.USD","BK1515","LU0072913022.USD","LU1328277881.USD","LU0067412154.USD","LU1951186391.HKD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1008478684.HKD","BK1191","HK0000165453.HKD","LU1152091168.USD","IE0008369823.USD","IE00BZ08YT58.USD","01093","LU0501845795.SGD","LU0880133367.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2039709279.SGD","LU1960683339.HKD","LU0140636845.USD","LU1226287792.SGD","LU1813983027.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664936258","title":"《股市簡訊》中國泰格醫藥A/H股齊跌,投行富瑞下調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2664936258","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664936258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 11:28","pubTimestamp":1788319715,"startTime":"0","endTime":"0","summary":"《股市简讯》中国泰格医药A/H股齐跌,投行富瑞下调目标价* 为制药公司代工开展临床试验的中国泰格医药A股300347.SZ周三早盘一度跌2.7%,其H股3347.HK亦下挫4.8%。* 美国投行富瑞在报告中表示,将泰格医药A股目标价由65元人民币下调至55元,其H股目标价由55港元下调至45港元。* 泰格医药H股今年迄今跌9.2%,同期恒生指数.HSI下滑2.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4T44U0B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","BK1583","300347","01099","BK1141","BK0028","BK1500","LU1146622755.USD","BK0119","BK0077","BK1197","BK1515","BK1576","BK0017","BK0216","BK0174","LU1115378108.SGD","LU0640798160.USD","LU1820825898.SGD","300228","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898526","title":"歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898526","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664898526?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 10:13","pubTimestamp":1788315180,"startTime":"0","endTime":"0","summary":"模拟交易客户端歌礼制药-B早盘涨超8%,截至发稿,股价上涨8.07%,现报10.31港元,成交额926.46万港元。近日,歌礼制药-B发布公告,ASC30用于长期体重管理的全球III期临床项目已完成首例受试者给药。ASC30是一款歌礼专有的、正在临床研究中的每日一次口服小分子胰高血糖素样肽-1受体激动剂,开发用于长期体重管理和糖尿病治疗。公告称,歌礼制药-B预计将于2028年第三季度公布AURORA III期临床项目的顶线数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-02/doc-iniqkzma1311603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01672","BK1191","01477","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664260860","title":"港股異動 | 歌禮制藥-B(01672.HK)升逾5% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664260860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664260860?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 09:49","pubTimestamp":1788313757,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","01672","01477","BK1191","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":219,"code":"91000000","status":"200"}]}}